Published in PLoS One on January 22, 2014
Inflammation and cancer. Nature (2002) 53.78
Pattern recognition receptors and inflammation. Cell (2010) 21.05
Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J Exp Med (1997) 4.06
Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science (2013) 3.91
Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet (2004) 3.05
A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control (2003) 2.24
IL-6 rescues resting mouse T cells from apoptosis. J Immunol (1997) 1.89
Cancer mortality among US men and women with asthma and hay fever. Am J Epidemiol (2005) 1.70
Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer. Br J Cancer (2005) 1.69
AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy (2008) 1.59
An overview of the association between allergy and cancer. Int J Cancer (2006) 1.45
Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy (2004) 1.41
Prior history of allergies and pancreatic cancer in the San Francisco Bay area. Am J Epidemiol (2003) 1.38
Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98. Biochem Biophys Res Commun (1999) 1.26
CD98 at the crossroads of adaptive immunity and cancer. J Cell Sci (2012) 1.24
CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J Biol Chem (2004) 1.22
VEGF, IL-18 and NO production by neutrophils and their serum levels in patients with oral cavity cancer. Cytokine (2005) 1.16
Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck. Hum Immunol (2003) 1.11
Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis. Respir Res (2005) 1.07
Innate immunity in allergic disease. Immunol Rev (2011) 1.06
Lung cancer risk in a population-based cohort of patients hospitalized for asthma in Sweden. Eur Respir J (2002) 1.05
Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma. Eur J Immunol (1999) 1.05
Novel cytokines and cytokine-producing T cells in allergic disorders. Allergy Asthma Proc (2011) 1.03
Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Cytokine (2004) 1.02
The activation pattern of blood leukocytes in head and neck squamous cell carcinoma is correlated to survival. PLoS One (2012) 0.98
Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck. Br J Cancer (2003) 0.95
Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer. Int J Mol Med (2010) 0.93
Cytokines as a therapeutic target for allergic diseases: a complex picture. Curr Pharm Des (2006) 0.92
Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors. Int J Immunopathol Pharmacol (2011) 0.88
In vitro T-lymphocyte function in head and neck cancer patients. Eur Arch Otorhinolaryngol (1997) 0.79